Most read

Consensus document of the Interventional Cardiology and Heart Rhythm Associations of the Spanish Society of Cardiology on the management of invasive cardiac procedure rooms during the COVID-19 coronavirus outbreak

Rafael Romaguera,a, Ignacio Cruz-González,b Soledad Ojeda,c Javier Jiménez-Candil,b David Calvo,d Javier García Seara,e Victoria Cañadas-Godoy,f Elena Calvo,a Salvatore Brugaletta,g María Sánchez Ledesma,h and Raúl Morenoi

aServicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Universidad de Barcelona, Barcelona, España

bServicio de Cardiología, Hospital Universitario de Salamanca, IBSAL, Salamanca, España

cServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, España

dServicio de Cardiología, Hospital Central de Asturias, Oviedo, Asturias, España

eServicio de Cardiología, Complejo Asistencial Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España

fServicio de Cardiología, Hospital Clínico San Carlos de Madrid, Madrid, España

gServicio de Cardiología, Hospital Clínic i Provincial de Barcelona, IDIBASP, Universitat de Barcelona, Barcelona, España

hUnidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario de Salamanca, Salamanca, España

iServicio de Cardiología, Hospital Universitario la Paz, Madrid, España


The undersigned authors are affiliated to the following scientific bodies: Interventional Cardiology Association of the Spanish Society of Cardiology: R. Romaguera (spokesperson), I. Cruz-González (president elect), S. Ojeda (spokesperson) and R. Moreno (president). Heart Rhythm Association of the Spanish Society of Cardiology: J. Jiménez-Candil (president), D. Calvo (president elect), J. García Seara (spokesperson), V. Cañadas-Godoy (spokesperson). Working Group on Interventional Cardiology of the Spanish Cardiovascular Nursing Association: E. Calvo.

REC Interv Cardiol. 2020;2:106-111

Considerations on the invasive management of ischemic and structural heart disease during the COVID-19 coronavirus outbreak.

Rafael Romaguera,a,1, Ignacio Cruz-González,b,1 Alfonso Jurado-Román,b,1 Soledad Ojeda,d Agustín Fernándz-Cisnal,e Pablo Jorge-Pérez,f Virginia Burgos-Palacios,g Albert Ariza-Solé,a Esteban López-de-Sa,c and Raúl Morenoc, ◊

aServicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Universidad de Barcelona, Barcelona, Spain

bServicio de Cardiología, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain

cServicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain

dServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain

eServicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain

fServicio de Cardiología, Complejo Hospitalario Universitario de Canarias, Tenerife, Santa Cruz de Tenerife, Spain

gServicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain


1R. Romaguera, I. Cruz-González, and A. Jurado-Román contributed equally to this work as lead authors.


The undersigned authors are affiliated to the following scientific bodies: Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology: R. Romaguera (chair), I. Cruz-González (president-elect), S. Ojeda (chair), and R. Moreno (president). Spanish Society of Cardiology Working Group on Ischemic Heart Disease and Acute Cardiovascular Care: E. López-de-Sá (president), A. Ariza-Solé (president-elect), P. Jorge-Pérez (chair), and V. Burgos-Palacios (chair).

REC Interv Cardiol. 2020;2:112-117

Quantitative flow ratio in myocardial infarction for the evaluation of non-infarct-related arteries. The QIMERA pilot study

Carlos Cortésa,b, Tania Rodríguez-Gabellaa, Hipólito Gutiérreza,c, Roman Arnolda,b,c, Ana María Serradora,b, Benigno Ramosa, Pablo Cataláa, Álvaro Aparisia, Williams Hinojosaa, Itziar Gómeza, Manuel Carrasco Moralejaa, Juan Luis Gutiérrez-Chicod, José A. San Romána,c and Ignacio J. Amat-Santosa,b,c,This email address is being protected from spambots. You need JavaScript enabled to view it.

aDepartamento de Cardiología, Hospital Clínico Universitario, Valladolid, España

bServicio de Cardiología, Instituto de Ciencias del Corazón, ICICORELAB, Hospital Clínico Universitario, Valladolid, España

cDepartamento de Cardiología, Hospital Clínico Universitario, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Valladolid, España

dDepartamento de Cardiología, Hospital Punta de Europa, Algeciras, Cádiz, España

REC Interv Cardiol. 2019;1:13-20

Impact of the COVID-19 pandemic on interventional cardiology activity in Spain

Oriol Rodríguez-Leor,a,b,c, Belén Cid-Álvarez,d, Soledad Ojeda,e Javier Martín-Moreiras,f José Ramón Rumoroso,g Ramón López-Palop,h Ana Serrador,i Ángel Cequier,j Rafael Romaguera,j Ignacio Cruz,f Armando Pérez de Prado,k and Raúl Moreno,l on behalf of all the participants of the ACI-SEC Infarction Code Registry ◊

aInstitut del Cor, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

bInstitut per la Recerca Germans Trias i Pujol, Badalona, Barcelona, Spain

cCIBERCV, Instituto de Salud Carlos III, Madrid, Spain

dDepartamento de Cardiología, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain

eDepartamento de Cardiología, Hospital Reina Sofía, Córdoba, Spain

fDepartamento de Cardiología, Hospital Clínico de Salamanca, Salamanca, Spain

gDepartamento de Cardiología, Hospital de Galdakao, Galdakao, Vizcaya, Spain

hDepartamento de Cardiología, Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain

iDepartamento de Cardiología, Hospital Clínico de Valladolid, Valladolid, Spain

jDepartamento de Cardiología, Hospital de Bellvitge, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain

kDepartamento de Cardiología, Hospital de León, León, Spain

lDepartamento de Cardiología, Hospital de La Paz, Madrid, Spain


◊ Annex 1 shows the participant centers and researchers in charge of each particular center.

REC Interv Cardiol. 2020;2:82-89

Evolut R implantation in Perceval bioprosthesis with periprosthetic leakage. How would I approach it?

Pablo Avanzasa,b,c,This email address is being protected from spambots. You need JavaScript enabled to view it.

aServicio de Cardiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España

bDepartamento de Medicina, Universidad de Oviedo, Oviedo, Asturias, España

cInstituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Asturias, España

REC Interv Cardiol. 2019;1:58-59

Aspirin-free antithrombotic management following coronary stenting. Myth or reality?

Davide Capodannoa, Roxana Mehranb and Dominick J. Angiolilloc,This email address is being protected from spambots. You need JavaScript enabled to view it.

aDivision of Cardiology, CAST, P.O. “Rodolico”, Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italia

bIcahn School of Medicine at Mount Sinai, New York, NY, Estados Unidos

cDivision of Cardiology, University of Florida College of Medicine, Jacksonville, FL, Estados Unidos

REC Interv Cardiol. 2019;1:62-66

The future of interventional cardiology

Spencer B. King IIIThis email address is being protected from spambots. You need JavaScript enabled to view it.

Emory University School of Medicine, Atlanta, Georgia, Estados Unidos

REC Interv Cardiol. 2019;1:4-5

A newborn journal of interventional cardiology. Where are we going? A dialogue between generations

Rodrigo Modoloa,b and Patrick W. Serruysc, This email address is being protected from spambots. You need JavaScript enabled to view it.

aDepartment of Cardiology, Academic Medical Center, University of Amsterdam, Ámsterdam, Países Bajos

bDepartment of Internal Medicine, Cardiology Division, University of Campinas (UNICAMP), Campinas, São Paulo, Brasil

cDepartment of Cardiology, Imperial College of London, Londres, Reino Unido

REC Interv Cardiol. 2019;1:6-10

Antithrombotic therapy after percutaneous revascularization in patients on chronic oral anticoagulation treatment

Juan M. Ruiz-Nodara, This email address is being protected from spambots. You need JavaScript enabled to view it. and José Luis Ferreirob

aServicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España

bÁrea de Enfermedades del Corazón, Hospital Universitario de Bellvitge – IDIBELL, Universidad de Barcelona, L’Hospitalet de Llobregat, Barcelona, España

REC Interv Cardiol. 2019;1:41-50